383 related articles for article (PubMed ID: 15846291)
1. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
[TBL] [Abstract][Full Text] [Related]
2. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
[TBL] [Abstract][Full Text] [Related]
4. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
5. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
6. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
7. A two-phase pathogenesis of graft-versus-host disease in mice.
van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
[TBL] [Abstract][Full Text] [Related]
8. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
9. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
10. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
[TBL] [Abstract][Full Text] [Related]
11. Liver T cell subsets and adhesion molecules in murine graft-versus-host disease.
Howell CD; De Victor D; Li J; Stephens J; Giorno RC
Bone Marrow Transplant; 1995 Jul; 16(1):139-45. PubMed ID: 7581114
[TBL] [Abstract][Full Text] [Related]
12. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
Miconnet I; de La Selle V; Bruley-Rosset M
Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
[TBL] [Abstract][Full Text] [Related]
13. [Expression of adhesion molecules in hepatic graft-versus-host disease].
Hayashishita N
Hokkaido Igaku Zasshi; 1994 May; 69(3):627-37, 639. PubMed ID: 7927186
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecule expression in human hepatic graft-versus-host disease.
Norton J; al-Saffar N; Sloane JP
Bone Marrow Transplant; 1992 Aug; 10(2):153-6. PubMed ID: 1381979
[TBL] [Abstract][Full Text] [Related]
15. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
16. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
17. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
Maier T; Holda JH; Claman HN
J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
[TBL] [Abstract][Full Text] [Related]
18. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
Hreha G; Jefferson DM; Yu CH; Grubman SA; Alsabeh R; Geller SA; Vierling JM
Hepatology; 1999 Aug; 30(2):358-71. PubMed ID: 10421641
[TBL] [Abstract][Full Text] [Related]
19. T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.
Eom HS; Rubio MT; Means TK; Luster AD; Sykes M
Exp Hematol; 2005 Dec; 33(12):1564-73. PubMed ID: 16338500
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]